AstraZeneca Pharma India reports net loss of Rs 8.14 crore in Q1

11 Aug 2012 Evaluate

AstraZeneca Pharma India has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has reported a net loss of Rs 8.14 crore for the quarter ended June 30, 2012 against net profit of Rs 16.74 crore for the corresponding period last fiscal. Total income decreased by 28.68% at Rs 99.12 crore during the quarter under review from Rs 138.98 crore in the year-ago period.

AstraZeneca operates through two entities, AstraZeneca Pharma India and AstraZeneca India in the country.

Astrazeneca Pharma I Share Price

8996.45 -128.10 (-1.40%)
16-Dec-2025 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.90
Dr. Reddys Lab 1278.00
Cipla 1498.55
Zydus Lifesciences 916.55
Lupin 2092.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×